Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has scheduled its second quarter 2025 financial results conference call and webcast for Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time. The company will discuss its Q2 2025 financial performance and recent portfolio developments.

Investors can access the live webcast through the Investors & Media section on www.kiniksa.com. For telephone participation, interested parties must pre-register to receive dial-in details. A replay will be available on the company's website within 48 hours after the event.

LONDON, July 24, 2025 (GLOBE NEWSWIRE) --  Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ^®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

FAQ

When is Kiniksa Pharmaceuticals (KNSA) reporting Q2 2025 earnings?

Kiniksa Pharmaceuticals will report its Q2 2025 earnings on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time.

How can investors access Kiniksa's Q2 2025 earnings call?

Investors can access the call through a live webcast on www.kiniksa.com under the Investors & Media section, or via telephone by pre-registering for dial-in details.

Will there be a replay available of Kiniksa's Q2 2025 earnings call?

Yes, a replay of the earnings call will be available on Kiniksa's website within 48 hours after the event.

What topics will be covered in Kiniksa's Q2 2025 earnings call?

The call will cover Kiniksa's second quarter 2025 financial results and provide updates on recent portfolio execution.